Beyond Breast Screening
Insights from a 53-Site Breast Program Transformation
Screening is foundational, but it doesn’t capture every patient at risk. Lifepoint Health’s enterprise rollout of Eon Breast revealed clinical and operational insights into the success of their breast care program.
- 6.2X higher likelihood of cancer diagnoses
- 1.3X more likely to be clinically high-risk at initial exam
- >50% of cancer diagnoses ineligible for screening
Risk doesn’t always enter through screening
While screening drives volume, clinical urgency is concentrated in incidental findings. Patients identified outside routine mammography pathways are typically higher risk and require faster, coordinated follow-up.
What the data shows:
- 1 in 8 net-new patients needing breast care are identified incidentally
- Incidental cancer patients are more likely to present as high-risk
- Over half of incidental cancers diagnosed were for patients traditionally not eligible for screening (age, gender)
Capacity is constrained by administrative burden
Breast programs aren't limited by patient demand, but by manual processes. MQSA documentation, phone and letter outreach, and follow-up tracking consume technologist time and restrict scalable growth.
Operational realities:
- Manual, disparate workflows across facilities
- Letter generation and outreach handled locally
- Inspection preparation consuming clinical hours
- Limited enterprise-wide performance visibility
One workflow for full visibility into every patient
Lifepoint unified breast screening and incidental findings into a single longitudinal workflow, ensuring timely follow-up, reducing variability across sites, and restoring operational capacity systemwide.
Key outcomes:
- 256 cancers diagnosed across screening and incidentals
- 2.7x increase in completed downstream exams per month
- 42k letters automated per month
- Mammography appointments reduced from 30 to 15 minutes
Get the insights to help you
build a program for every patient who needs breast care.
